2015
DOI: 10.1016/j.brat.2015.07.005
|View full text |Cite
|
Sign up to set email alerts
|

Cognitive behavior therapy for comorbid migraine and/or tension-type headache and major depressive disorder: An exploratory randomized controlled trial

Abstract: Numerous studies have demonstrated comorbidity between migraine and tension-type headache on the one hand, and depression on the other. Presence of depression is a negative prognostic indicator for behavioral treatment of headaches. Despite the recognised comorbidity, there is a limited research literature evaluating interventions designed for comorbid headaches and depression. Sixty six participants (49 female, 17 male) suffering from migraine and/or tension-type headache and major depressive disorder were ra… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
33
0

Year Published

2015
2015
2021
2021

Publication Types

Select...
8
2

Relationship

1
9

Authors

Journals

citations
Cited by 53 publications
(34 citation statements)
references
References 49 publications
(49 reference statements)
1
33
0
Order By: Relevance
“…CBT treatments to reduce depressive and anxious symptoms are similar in many ways, and yet also differ in scope and content when compared with CBT targeting migraine symptoms specifically. Recent literature has begun to address questions about how to modify existing CBT treatments to address people with migraine and comorbid psychiatric disorders (38). Intervention development efforts, and a series of early-stage randomized clinical trials, are warranted to identify potentially effective methods of addressing elevated psychiatric symptoms in people with migraine.…”
Section: Discussionmentioning
confidence: 99%
“…CBT treatments to reduce depressive and anxious symptoms are similar in many ways, and yet also differ in scope and content when compared with CBT targeting migraine symptoms specifically. Recent literature has begun to address questions about how to modify existing CBT treatments to address people with migraine and comorbid psychiatric disorders (38). Intervention development efforts, and a series of early-stage randomized clinical trials, are warranted to identify potentially effective methods of addressing elevated psychiatric symptoms in people with migraine.…”
Section: Discussionmentioning
confidence: 99%
“…Evidence to the contrary is accumulating, however. 38,39 Replicating these results in larger samples and with other comorbidities offers hope for a new era of treatment development, in which well-established behavioral interventions for both migraine and the comorbid condition are combined into a single integrated treatment that can be administered in conjunction with headache-specific pharmacotherapy. 38,39 Replicating these results in larger samples and with other comorbidities offers hope for a new era of treatment development, in which well-established behavioral interventions for both migraine and the comorbid condition are combined into a single integrated treatment that can be administered in conjunction with headache-specific pharmacotherapy.…”
Section: Discussionmentioning
confidence: 99%
“…Fostering headache-related acceptance may thus be particularly important for people with migraine with high levels of depression and anxiety symptoms. Incorporating therapeutic methods such as Acceptance and Commitment Therapy 55 to enhance pain willingness (willingness to experience or endure migraine) and activity engagement (remaining engaged in valued activities despite migraine), such as through progressive exposure to headache stimuli or behavioral activation, 56,57 could be useful additions to existing well-established biobehavioral interventions including cognitive-behavioral treatments, biofeedback and relaxation training to reduce migraine-related disability, particularly among patients with depression and/or anxiety symptoms. 58 …”
Section: Discussionmentioning
confidence: 99%